UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549

OMB APPROVAL

 

OMB Number:  3235-0582

 

Expires:    April 30, 2009

 

Estimated average burden hours per response......14.4

 

FORM N-PX

 

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

 

Investment Company Act file number 811- 06565

 

H&Q Life Sciences Investors

(Exact name of registrant as specified in charter)

 

30 Rowes Wharf, Boston, MA

 

02110

(Address of principal executive offices)

 

(Zip code)

 

Kathleen Eckert

H&Q Life Sciences Investors

30 Rowes Wharf, Boston MA 02110

(Name and address of agent for service)

 

Registrant’s telephone number, including area code: 617 772-8500

 

Date of fiscal year end:       September 30

 

Date of reporting period:    7/1/05-6/30/06

 

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

 

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC  20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

 

 


 

Item 1. Proxy Voting Record.

 


 

HQL N-PX for the period July 1, 2005 to June 30, 2006

 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

004225108

 

ACAD

 

Acadia Pharmaceuticals, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/13/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/21/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Uli Hacksell

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Torsten Rasmussen

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Alan Walton

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection by the audit committee of our board of directors of Pricewaterhousecoopers LLP as our independent registered public accountanting firm for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

006864102

 

ADZA

 

Adeza Biomedical Corporation

 

 

 

 

 

 

 

 

Meeting Date:

 

6/6/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/17/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Andrew E. Senyei, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Michael P. Downey

 

For

 

Yes

 

For

 

Management

2

 

To ratify the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

00826T108

 

AFFX

 

Affymetrix, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/15/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/20/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Stephen P.A. Fodor, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Paul Berg, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director S.D. Desmond-Hellmann

 

For

 

Yes

 

For

 

Management

1

 

Elect Director John D. Diekman, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Vernon R. Loucks, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director David B. Singer

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Robert H. Trice, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director John A. Young

 

For

 

Yes

 

For

 

Management

2

 

To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the company for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

1


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

 

 

 

 

Agilix Corporation

 

 

 

 

 

 

 

 

Action by Written Consent:

 

8/29/2005

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Dominic J. Rodrigues

 

For

 

Yes

 

For

 

Management

2

 

Approval of changes associated with one of the Company’s technologies

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

Agilix Corporation

 

 

 

 

 

 

 

 

Action by Written Consent:

 

2/14/2006

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approve asset purchase agreement

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

Agilix Corporation

 

 

 

 

 

 

 

 

Action by Written Consent:

 

4/7/2006

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Authorize form, terms and provisions of plan of liquidation

 

For

 

Yes

 

For

 

Management

 

009728106

 

AKN

 

Akorn, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/25/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/7/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director John N. Kapoor, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Arthur S. Przybyl

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Jerry N. Ellis

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Ronald M. Johnson

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Jerry I. Treppel

 

For

 

Yes

 

For

 

Management

2

 

Proposal to ratify the selection of BDO Seidman, LLP to serve as Akorn’s independent registered public accounting firm for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

2


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

016255101

 

ALGN

 

Align Technology, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/24/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/31/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director H. Kent Bowen

 

For

 

Yes

 

For

 

Management

1

 

Elect Director David E. Collins

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Joseph Lacob

 

For

 

Yes

 

For

 

Management

1

 

Elect Director C. Raymond Larkin, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director George J. Morrow

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Thomas M. Prescott

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Greg J. Santora

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Warren S. Thaler

 

For

 

Yes

 

For

 

Management

2

 

Ratification of selection of independent registered public accountants: proposal to ratify the appointment of Pricewatershousecoopers LLP as Align Technology, Inc.’s independent registered public accountants for the fiscal year ending December 31, 2006.

 

For

 

Yes

 

For

 

Management

 

031162100

 

AMGN

 

Amgen, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/10/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/13/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Frederick W. Gluck

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Adm. J. Paul Reason

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Donald B. Rice

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Leonard D. Schaeffer

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of Ernst & Young LLP as the company’s independent registered public accountants for the year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

3

 

Stockholder proposal #1 (stock retention guidelines)

 

Against

 

Yes

 

Against

 

Shareholder

3

 

Stockholder proposal #2 (executive compensation)

 

Against

 

Yes

 

Against

 

Shareholder

3

 

Stockholder proposal #3 (shareholder rights plans)

 

Against

 

Yes

 

For

 

Shareholder

3

 

Stockholder proposal #4 (animal welfare policy)

 

Against

 

Yes

 

Against

 

Shareholder

3

 

Stockholder proposal #5 (majority elections)

 

Against

 

Yes

 

Against

 

Shareholder

3

 

Stockholder proposal #6 (corporate political contributions)

 

For

 

Yes

 

For

 

Shareholder

 

3


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

038020202

 

CRA

 

Applera Corporation - Celera

 

 

 

 

 

 

 

 

Meeting Date:

 

10/20/2005

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

9/1/2005

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Richard H. Ayers

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Jean-Luc Belingard

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Robert H. Hayes

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Arnold J. Levine

 

For

 

Yes

 

For

 

Management

1

 

Elect Director William H. Longfield

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Theodore E. Martin

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Carolyn W. Slayman

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Orin R. Smith

 

For

 

Yes

 

For

 

Management

1

 

Elect Director James R. Tobin

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Tony L. White

 

For

 

Yes

 

For

 

Management

2

 

Ratification of the selection of Pricewaterhousecoopers LLP as independent registered public accounting firm for the fiscal year ending June 30, 2006.

 

For

 

Yes

 

For

 

Management

 

04033A100

 

ARIA

 

Ariad Pharmaceuticals, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/14/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/19/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Harvey J. Berger, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Michael D. Kishbauch

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Burton E. Sobel, MD

 

For

 

Yes

 

For

 

Management

2

 

Approval of adoption of the 2006 long-term incentive plan and reservation of 4,500,000 shares of common stock for stock options and other equity based grants which may be awarded under the 2006 long-term incentive plan

 

For

 

Yes

 

For

 

Management

3

 

Ratification of selection of independent registered public accounting firm: the audit committee of the board of directors has selected Deloitte & Touche LLP to be our independent registered public accounting firm for the year ending December 31, 2006. The board of directors has ratified this selection.

 

For

 

Yes

 

For

 

Management

 

4


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

05346P106

 

AVRX

 

Avalon Pharmaceuticals, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/9/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/28/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director A.G. Walton, Ph.D., Dsc.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Kenneth C. Carter, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Michael R. Kurman, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Bradley G. Lorimier

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Ivor Royston, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect Director William A. Scott, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Patrick Van Beneden

 

For

 

Yes

 

For

 

Management

1

 

Elect Director William H. Washecka

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Raymond J. Whitaker, Ph.D.

 

For

 

Yes

 

For

 

Management

2

 

To approve the amendment of the company’s 2005 omnibus long-term incentive plan (the “incentive plan”) to increase the number of shares available for issuance under the incentive plan from 989,738 shares to 1,581,582 shares.

 

For

 

Yes

 

For

 

Management

3

 

To ratify the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

05346P106

 

AVRX

 

Avalon Pharmaceuticals, Inc.

 

 

 

 

 

 

 

 

Action by Written Consent:

 

8/4/2005

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Revision of Charter

 

For

 

No

 

None

 

Management

2

 

Revision of By-laws

 

For

 

No

 

None

 

Management

3

 

Adoption of 2005 equity incentive plan

 

For

 

No

 

None

 

Management

 

05346P106

 

AVRX

 

Avalon Pharmaceuticals, Inc.

 

 

 

 

 

 

 

 

Action by Written Consent:

 

3/17/2006

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approve waiver of registration rights to include shares of restricted stock in resale registration statement

 

For

 

No

 

None

 

Management

 

06850R108

 

BRTX

 

Barrier Therapeutics, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/21/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/24/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Carl W. Ehmann, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Peter Ernster

 

For

 

Yes

 

For

 

Management

1

 

Elect Carol Raphael

 

For

 

Yes

 

For

 

Management

2

 

To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the company for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

5


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

09059N100

 

BIVN

 

Bioenvision, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

12/12/2005

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

10/17/2005

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Christopher B. Wood, M.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Michael Kauffman, M.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Thomas Scott Nelson, C.A.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Steven A. Elms

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Andrew Schiff, M.D.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

CardioNet, Inc.

 

 

 

 

 

 

 

 

Action by Written Consent:

 

8/15/2005

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Authorize and approve bridge financing and amendment with the Secretary of the State of California

 

For

 

Yes

 

For

 

Management

2

 

Waive of rights of first offer

 

For

 

Yes

 

For

 

Management

3

 

Authorize appropriate officers of the Company to make filings and applications

 

For

 

Yes

 

For

 

Management

4

 

Ratify, approve and confirm all actions of the officers of the Company in connection with the amendment and bridge financing

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

CardioNet, Inc.

 

 

 

 

 

 

 

 

Action by Written Consent:

 

1/26/2006

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Harry T. Rein

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

CardioNet, Inc.

 

 

 

 

 

 

 

 

Action by Written Consent:

 

2/20/2006

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Consent to extension of maturity date

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

CardioNet, Inc.

 

 

 

 

 

 

 

 

Action by Written Consent:

 

3/31/2006

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Bruce KenKnight

 

For

 

Yes

 

For

 

Management

 

6


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

 

 

 

 

CardioNet, Inc.

 

 

 

 

 

 

 

 

Action by Written Consent:

 

5/1/2006

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Authorize and approve Bridge Financing

 

For

 

Yes

 

For

 

Management

2

 

Waive of Rights of First Offer

 

For

 

Yes

 

For

 

Management

3

 

Authorize appropriate officers of the Company to make filings and applications

 

For

 

Yes

 

For

 

Management

4

 

Ratify, approve and confirm all actions of the officers of the Company in connection with the amendment and bridge financing

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

Ceres, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

7/18/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

6/28/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Walter De Logi

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Pascal Brandys

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Frank Bulens

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Raymond Debbane

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Robert Goldberg

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Richard Hamilton

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Thomas Kiley

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Edmund Olivier

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Floris Vansina

 

For

 

Yes

 

For

 

Management

2

 

Ratification of appointment of KPMG LLP as independent public accountants

 

For

 

Yes

 

For

 

Management

 

208264101

 

CONR

 

Conor Medsystems, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/21/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/25/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director John F. Shanley

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Steven B. Gerber, MD

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of Ernst & Young LLP as Conor Medsystems’ independent registered public accounting firm for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

7


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

 

 

 

 

Concentric Medical, Inc.

 

 

 

 

 

 

 

 

Action by Written Consent:

 

7/22/2005

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Direct Edward Unkart

 

For

 

No

 

 

 

Management

1

 

Omnibus resolution

 

For

 

No

 

 

 

Management

 

 

 

 

 

Corus Pharma, Inc.

 

 

 

 

 

 

 

 

Action by Written Consent:

 

4/10/2006

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approve amendment and restatement of certificate of incorporation

 

For

 

Yes

 

For

 

Management

2

 

Approve amendment to 2001 stock plan

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

Corus Pharma, Inc.

 

 

 

 

 

 

 

 

Action by Written Consent:

 

4/11/2006

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Adoption of agreement and plan of merger

 

For

 

No

 

None

 

Management

 

22674T105

 

CRTX

 

Critical Therapeutics, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

4/25/2006

 

 

 

Meeting Type:

 

 

 

 

 

 

Record Date:

 

3/24/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Richard W. Dugan

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Christopher Mirabelli

 

For

 

Yes

 

For

 

Management

1

 

Elect Director James B. Tananbaum

 

For

 

Yes

 

For

 

Management

2

 

To approve the adoption of the company’s 2006 employee stock purchase plan, under which 400,000 shares of common stock will be authorized for issuance.

 

For

 

Yes

 

For

 

Management

3

 

To ratify the selection by the board of directors of Deloitte & Touche LLP as the company’s registered public accounting firm for the fiscal year ending December 31, 2006.

 

For

 

Yes

 

For

 

Management

 

229678107

 

CBST

 

Cubist Pharmaceuticals, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/8/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/12/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director David W. Martin, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Kenneth M. Bate

 

For

 

Yes

 

For

 

Management

2

 

Ratify the selection of Pricewaterhousecoopers LLP as our independent auditor for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

3

 

Ratify, adopt and approve the amended and restated 2002 directors’ equity incentive plan.

 

For

 

Yes

 

For

 

Management

 

8


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

231269101

 

CRIS

 

Curis, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/1/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/3/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect James R. Mcnab, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect James R. Tobin

 

For

 

Yes

 

For

 

Management

2

 

To ratify the appointment of Pricewaterhousecoopers LLP as the company’s independent public accountants for the current fiscal year.

 

For

 

Yes

 

For

 

Management

 

23282W100

 

CYTK

 

Cytokinetics, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/25/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/31/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director James A. Spudich

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Charles Homcy

 

For

 

Yes

 

For

 

Management

2

 

Selction of independent registered public accounting firm

 

For

 

Yes

 

For

 

Management

3

 

Approval of amendment to the company’s 2004 stock purchase plan

 

For

 

Yes

 

For

 

Management

 

243586104

 

DCGN

 

deCode Genetics, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/9/2005

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/31/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director J. Neal Armstrong

 

For

 

Yes

 

For

 

Management

1

 

Elect Director James R. Beery

 

For

 

Yes

 

For

 

Management

2

 

Ratification of the appointment of Deloitte & Touche LLP to serve as the company’s independent registered public accounting firm for the year ending December 31, 2006.

 

For

 

Yes

 

For

 

Management

3

 

Approval of the deCode Genetics, Inc. 2006 equity incentive plan

 

For

 

Yes

 

Against

 

Management

 

9


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

249908104

 

DEPO

 

Depomed, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/9/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/21/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director John W. Fara, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director G. Steven Burrill

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Gerald T. Proehl

 

For

 

Yes

 

For

 

Management

1

 

Elect Director John W. Shell, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Craig R. Smith, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Peter D. Staple

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Julian N. Stern

 

For

 

Yes

 

For

 

Management

2

 

To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the company for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

259858108

 

DOVP

 

Dov Pharmaceuticals, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/22/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/5/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Daniel S. Van Riper

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Dennis G. Podlesak

 

For

 

Yes

 

For

 

Management

2

 

To approve an amendment to the company’s 2000 stock option and grant plan to increase the total number of shares of common stock authorized for issuance under the plan by 1,000,000 to 4,692,090 from 3,692,090

 

For

 

Yes

 

For

 

Management

3

 

To ratify the selection of Pricewaterhousecoopers LLP as independent registered public accounting firm for its fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

29076V109

 

EMAG

 

Emageon, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/25/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/21/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Roddy J.H. Clark

 

For

 

Yes

 

For

 

Management

1

 

Elect Director John W. Thompson

 

For

 

Yes

 

For

 

Management

2

 

Proposal to ratify the appointment of Ernst & Young LLP as the company’s independent registered public acocunting firm for the current fiscal year.

 

For

 

Yes

 

For

 

Management

 

10


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

29256X107

 

ENCY

 

Encysive Pharmaceuticals, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/12/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/30/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director John M. Pietruski

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Ron J. Anderson

 

For

 

Yes

 

For

 

Management

1

 

Elect Director J. Kevin Buchi

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Robert J. Cruikshank

 

For

 

Yes

 

For

 

Management

1

 

Elect Director John H. Dillon, II

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Richard A.F. Dixon

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Bruce D. Given

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Suzanne Oparil

 

For

 

Yes

 

For

 

Management

1

 

Elect Director James A. Thomson

 

For

 

Yes

 

For

 

Management

1

 

Elect Director James T. Willerson

 

For

 

Yes

 

For

 

Management

 

30161Q104

 

EXEL

 

Exelixis, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/1/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/3/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Charles Cohen, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director George Poste, DVM, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Jack Wyszomierski

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending Dec. 31, 2006

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

Galileo Pharmaceuticals, Inc.

 

 

 

 

 

 

 

 

Action by Written Consent:

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect to liquidate affairs of the Company

 

For

 

Yes

 

For

 

Management

 

368710406

 

DNA

 

Genentech, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

4/20/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

2/22/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Herbrt W. Boyer

 

For

 

Yes

 

For

 

Management

1

 

Elect Director William M. Burns

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Erich Hunziker

 

For

 

Yes

 

For

 

Management

1

 

Elect Jonathan K.C. Knowles

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Arthur D. Levinson

 

For

 

Yes

 

For

 

Management

1

 

Elect Debra L. Reed

 

For

 

Yes

 

For

 

Management

1

 

Elect Charles A. Sanders

 

For

 

Yes

 

For

 

Management

2

 

To approve an amendment to the 1991 employee stock plan

 

For

 

Yes

 

For

 

Management

3

 

To ratify the selection of Ernst & Young LLP as independent registered public accounting firm of Genentech for the year ending December 31, 2006.

 

For

 

Yes

 

For

 

Management

 

11


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

372917104

 

GENZ

 

Genzyme Corporation

 

 

 

 

 

 

 

 

Meeting Date:

 

5/25/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/31/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Dr. Victor Dzau

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Senator Connie Mack

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Henri A. Termeer

 

For

 

Yes

 

For

 

Management

2

 

A proposal to amend the 2004 equity incentive plan to provide for the grant of restricted stock and restricted stock units and increase the number of shares of common stock covered by the plan by 7,000,000 shares

 

For

 

Yes

 

For

 

Management

3

 

A proposal to amend the 1998 director stock option plan to increase the number of shares of common stock covered by the plan by 300,000 shares

 

For

 

Yes

 

For

 

Management

4

 

The amendment and restatement of our restated articles of organization to declassify our board so that, beginning in 2007, all directors are elected for one year terms

 

For

 

Yes

 

For

 

Management

5

 

A proposal to ratify the selection of independent auditors for 2006

 

For

 

Yes

 

For

 

Management

6

 

A shareholder proposal that executive severance arrangements be approved by shareholder

 

Against

 

Yes

 

Against

 

Shareholder

 

12


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

375558103

 

GILD

 

Gilead Sciences, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/10/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/22/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Paul Berg

 

For

 

Yes

 

For

 

Management

1

 

Elect Director John F. Cogan

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Etienne F. Davignon

 

For

 

Yes

 

For

 

Management

1

 

Elect Director James M. Denny

 

For

 

Yes

 

For

 

Management

1

 

Elect Director John W. Madigan

 

For

 

Yes

 

For

 

Management

1

 

Elect Director John C. Martin

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Gordon E. Moore

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Nicholas G. Moore

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Gayle E. Wilson

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of Ernst & Young LLP by the audit committee of the board of directors as the independent registered public accounting firm of Gilead for the fiscal year ending December 31, 2006.

 

For

 

Yes

 

For

 

Management

3

 

To approve an amendment to Gilead’s 2004 equity incentive plan

 

For

 

Yes

 

For

 

Management

4

 

To approve Gilead’s code section 162(M) bonus plan and certain performance-based provisions thereunder.

 

For

 

Yes

 

For

 

Management

5

 

To approve an amendment to Gilead’s restated certificate of incorporation to increase the authorized number of shares of Gilead’s common stock from 700,000,000 to 1,400,000,000 shares.

 

For

 

Yes

 

For

 

Management

6

 

To approve a stockholder proposal requesting a report on the HIV/AIDS, tuberculosis, and malaria pandemic

 

Against

 

Yes

 

Against

 

Shareholder

 

45166R204

 

IDIX

 

Idenix Pharmaceuticals, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/14/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/18/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director J-P. Sommadossi, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Charles W. Cramb

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Thomas Ebeling

 

For

 

Yes

 

For

 

Management

1

 

Elect Director W.T. Hockmeyer, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Thomas R. Hodgson

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Robert E. Pelzer

 

For

 

Yes

 

For

 

Management

1

 

Elect Director D. Pollard-Knight, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Pamela Thomas-Graham

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of Pricewaterhousecoopers LLP as the company’s independent registered public accounting firm for the current fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

13


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

45168D104

 

IDXX

 

IDEXX Laboratories, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/10/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/20/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director William T. End

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Barry C. Johnson, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Brian P. Mckeon

 

For

 

Yes

 

For

 

Management

2

 

To approve an amendment to the company’s restated certificate of  incorporation increasing the number of authorized shares of common stock form 60,000,000 to 120,000,000

 

For

 

Yes

 

For

 

Management

3

 

Ratification of appointment of independent registered public accounting firm. To ratify the selection by the audit committee of the board of directors of pricewaterhousecoopers LLP as the company’s independent registered public accounting firm for the current fiscal year.

 

For

 

Yes

 

For

 

Management

 

45719T103

 

INHX

 

Inhibitex, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/18/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/31/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Carl E. Brooks

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Robert A. Hamm

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Louis W. Sullivan

 

For

 

Yes

 

For

 

Management

2

 

Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for Inhibitex, Inc.

 

For

 

Yes

 

For

 

Management

 

457669208

 

INSM

 

Insmed Corporation

 

 

 

 

 

 

 

 

Meeting Date:

 

5/10/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/17/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Geoffrey Allan, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Melvin Sharoky, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Randall W. Whitcomb, MD

 

For

 

Yes

 

For

 

Management

2

 

Ratification of the selection of Ernst & Young LLP as the independent auditors for Insmed for the fiscal year ending December 31, 2006.

 

For

 

Yes

 

For

 

Management

 

457733103

 

ISPH

 

Inspire Pharmaceuticals, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/13/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/17/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Alan F. Holmer

 

For

 

Yes

 

For

 

Management

1

 

Elect Director William R. Ringo, Jr.

 

For

 

Yes

 

For

 

Management

2

 

Ratification of selection of Pricewaterhousecoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

3

 

Approval of a proposal to amend and restate our restated certificate of incorporation to increase the total authorized shares of common stock, par value $0.001 per share, of the company from 60,000,000 to 100,000,000

 

For

 

Yes

 

For

 

Management

 

14


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

461169104

 

ILSE

 

Intralase Corporation

 

 

 

 

 

 

 

 

Meeting Date:

 

7/20/2005

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

6/24/2005

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Thomas S. Porter

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Jay T. Holmes

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of Deloitte & Touche, LLP as independent auditors of the company for its fiscal year ending December 31, 2005.

 

For

 

Yes

 

For

 

Management

 

465823102

 

IVX

 

Ivax Corporation

 

 

 

 

 

 

 

 

Meeting Date:

 

8/3/2005

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/29/2005

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Betty G. Amos

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Mark Andrews

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Jack Fishman, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Neil Flanzraich

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Phillip Frost, M.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Jane Hsiao, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Richard M. Krasno, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director David A. Lieberman

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Richard C. Pfenniger, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Bertram Pitt, M.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Z.P. Zachariah, M.D.

 

For

 

Yes

 

For

 

Management

 

465823102

 

IVX

 

Ivax Corporation

 

 

 

 

 

 

 

 

Meeting Date:

 

10/27/2005

 

 

 

Meeting Type:

 

Special

 

 

 

 

Record Date:

 

9/30/2005

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To approve the agreement and plan of merger, dated as of July 25, 2005, by and among Ivax Corporation, Teva Pharmaceuticals Industries Ltd., Ivory Acquisition Sub, Inc. and Ivory Acquisition Sub II, Inc.

 

For

 

Yes

 

For

 

Management

 

15


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

50064W107

 

KOSN

 

Kosan Biosciences, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/25/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/31/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Kevan Clemens, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Jean Deleage, Ph.D.

 

For

 

Yes

 

For

 

Management

2

 

Approval of 2006 equity incentive plan

 

For

 

Yes

 

For

 

Management

3

 

Ratification of selection of independent registered public accounting firm

 

For

 

Yes

 

For

 

Management

 

528872104

 

LEXG

 

Lexicon Genetics, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

4/26/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/7/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Arthur T. Sands, M.D. Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Frank Palantoni

 

For

 

Yes

 

For

 

Management

2

 

Ratification and approval of the appointment of Ernst & Young LLP as the company’s independent auditors for the fiscal year ending Dec. 31, 2006.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

Masimo Corporation

 

 

 

 

 

 

 

 

 

Action by Written Consent:

 

8/29/2005

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To approve the amendment to the cross-licensing agreement between Masimo Corporation and Masimo Laboratories

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

Masimo Corporation

 

 

 

 

 

 

 

 

 

Action by Written Consent:

 

2/28/2006

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To approve an amendment to the Corporation’s Amended and Restated Certificate of Incorporation

 

For

 

Yes

 

For

 

Management

2

 

To approve an amendment to the Corporation’s 2004 IncentiveStock Option, Nonqualified Stock Option and Restricted Stock Purchase Plan

 

For

 

Yes

 

For

 

Management

 

16


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

584699102

 

MEDI

 

Medimmune, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/25/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/31/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Wayne T. Hockmeyer

 

For

 

Yes

 

For

 

Management

1

 

Elect Director David M. Mott

 

For

 

Yes

 

For

 

Management

1

 

Elect Director David Baltimore

 

For

 

Yes

 

For

 

Management

1

 

Elect Director M. James Barrett

 

For

 

Yes

 

For

 

Management

1

 

Elect Director James H. Cavanaugh

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Barbara H. Franklin

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Gordon S. Macklin

 

For

 

Yes

 

For

 

Management

1

 

Elect Director George M. Milne, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Elizabeth H.S. Wyatt

 

For

 

Yes

 

For

 

Management

2

 

To approve an amendment to the 2003 non-employee directors stock option plan

 

For

 

Yes

 

For

 

Management

3

 

To approve and ratify the appointment of Pricewaterhousecoopers LLP as independent registered public accounting form for 2006

 

For

 

Yes

 

For

 

Management

 

60877T100

 

MNTA

 

Momenta Pharmaceuticals, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/15/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/25/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director John K. Clarke

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Robert S. Langer, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Stephen T. Reeders

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection by the board of directors of Ernst & Young LLP as the company’s independent auditors for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

62856E104

 

MYOG

 

Myogen, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/4/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/24/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director M.R. Bristow, MD, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Kirk K. Calhoun

 

For

 

Yes

 

For

 

Management

1

 

Elect Director J. William Freytag, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Judith A. Hemberger, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Jerry T. Jackson

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Daniel J. Mitchell

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Arnold L. Oronsky, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Michael J. Valentino

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection by the audit committee of the board of directors of Ernst & Young as independent registered public accounting firm of the company for its fiscal year ending December 31, 2006.

 

For

 

Yes

 

For

 

Management

 

17


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

62855J104

 

MYGN

 

Myriad Genetics, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

1/6/2006

 

 

 

Meeting Type:

 

Special

 

 

 

 

Record Date:

 

11/15/2005

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Proposal to amend the 2003 Employee, Director and Consultant stock option plan to increase the number of shares of common stock available for issuance thereunder by 1,200,000 shares.

 

For

 

Yes

 

Against

 

Management

 

64124E106

 

NRGN

 

Neurogen Corporation

 

 

 

 

 

 

 

 

Meeting Date:

 

6/9/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/13/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Felix J. Baker

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Julian C. Baker

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Eran Broshy

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Stephen R. Davis

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Stewart Hen

 

For

 

Yes

 

For

 

Management

1

 

Elect Director William H. Koster

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Jonathan S. Leff

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Craig Saxton

 

For

 

Yes

 

For

 

Management

1

 

Elect Director John Simon

 

For

 

Yes

 

For

 

Management

2

 

To adopt an amendment to the Neurogen Corporation 2000 non-employee directors stock option program to increase the number of shares available for issuance under the program from 570,000 shares to 820,000 shares

 

For

 

Yes

 

For

 

Management

3

 

To adopt an amendment to the amended and restated Neurogen Corporation 2001 stock option plan to increase the number of shares available for issuance under the plan from 3,500,000 shares to 4,500,000 shares

 

For

 

Yes

 

For

 

Management

4

 

To ratify the appointment by the board of directors of Pricewaterhousecoopers LLP as the independent registered public accountatnts for the compay for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

18


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

654798503

 

NTMD

 

Nitromed, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/17/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/3/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect Director Argeris Karabelas Ph.D.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect Director Robert S. Cohen

 

For

 

Yes

 

For

 

Management

 

1

 

Elect Director Frank L. Douglas, MD, Ph.D.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect Director Zola Horovitz, Ph.D.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect Director Mark Leschly

 

For

 

Yes

 

For

 

Management

 

1

 

Elect Director John W. Littlechild

 

For

 

Yes

 

For

 

Management

 

1

 

Elect Director Joseph Loscalzo, MD, Ph.D.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect Director Davey S. Scoon

 

For

 

Yes

 

For

 

Management

 

2

 

To adopt the amendment to the company’s 2003 employee stock purchase plan

 

For

 

Yes

 

For

 

Management

 

3

 

To ratify the selection by the audit committee of Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2006.

 

For

 

Yes

 

For

 

Management

 

 

670009109

 

NOVN

 

Noven Pharmaceuticals, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/23/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/27/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Sidney Braginsky

 

For

 

Yes

 

For

 

Management

1

 

Elect Director John G. Clarkson, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Donald A. Denkhaus

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Pedro P. Granadillo

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Robert G. Savage

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Robert C. Strauss

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Wayne P. Yetter

 

For

 

Yes

 

For

 

Management

2

 

Proposal to ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2006.

 

For

 

Yes

 

For

 

Management

 

19


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

 

 

 

 

OmniSonics Medical Technologies, Inc.

 

 

 

 

 

 

 

Action by Written Consent:

 

7/8/2005

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director John L. Brooks, III

 

For

 

No

 

None

 

Management

1

 

Elect Director Donald H. Woods

 

For

 

No

 

None

 

Management

1

 

Elect Director Stephen Bloch, MD

 

For

 

No

 

None

 

Management

1

 

Elect Director Robert J. More

 

For

 

No

 

None

 

Management

1

 

Elect Director Bruce Krattenmaker

 

For

 

No

 

None

 

Management

1

 

Elect Director David Stewart

 

For

 

No

 

None

 

Management

1

 

Elect Director Richard Ganz

 

For

 

No

 

None

 

Management

 

 

 

 

 

OmniSonics Medical Technologies, Inc.

 

 

 

 

 

 

 

Action by Written Consent:

 

10/17/2005

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approve amendment to 2002 equity incentive plan

 

For

 

No

 

None

 

Management

2

 

Approve amendment to the fourth amended and restated certificate of incorporation

 

For

 

No

 

None

 

Management

3

 

Approve amendment to the fourth amended and restated stockholder rights agreement

 

For

 

No

 

None

 

Management

4

 

Approval of grant stock options

 

For

 

No

 

None

 

Management

 

 

 

 

 

OmniSonics Medical Technologies, Inc.

 

 

 

 

 

 

 

Action by Written Consent:

 

6/30/2006

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director John L. Brooks, III

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Donald H. Woods

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Stephen Bloch, M.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Robert J. More

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Bruce Krattenmaker

 

For

 

Yes

 

For

 

Management

1

 

Elect Director David Stewart

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Richard Ganz

 

For

 

Yes

 

For

 

Management

 

20


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

68573C107

 

ORCH

 

Orchid Cellmark, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

7/6/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

5/19/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director George H. Poste

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Nicole S. Williams

 

For

 

Yes

 

For

 

Management

2

 

Proposal to ratify the appointment of KPMG LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

68750U102

 

VITA

 

Orthovita, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

7/25/2005

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/28/2005

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Morris Cheston, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director David Fitzgerald

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Joseph L. Harris

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Antony Koblish

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Robert M. Levande

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Mary Paetzold

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Russell B. Whitman

 

For

 

Yes

 

For

 

Management

2

 

Approval of proposed amendment to the 1997 equity compensation plan to increase the number of shares of Orthovita’s common stock available for issuance under the plan.

 

For

 

Yes

 

For

 

Management

 

709754105

 

PPCO

 

Penwest Pharmaceuticals Co.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/7/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/14/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Robert J. Hennessey

 

For

 

Yes

 

For

 

Management

1

 

Elect Director John N. Staniforth

 

For

 

Yes

 

For

 

Management

2

 

Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the company for the current fisca year

 

For

 

Yes

 

For

 

Management

 

7171EP101

 

PCOP

 

Pharmacopeia Drug Discovery, Inc.

 

 

 

 

 

 

Meeting Date:

 

5/4/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/14/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Carol A. Ammon

 

For

 

Yes

 

For

 

Management

1

 

Elect Paul A. Bartlett, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Joseph A. Mollica, Ph.D.

 

For

 

Yes

 

For

 

Management

2

 

Ratification of the appointment of Ernst & Young LLP as the company’s independent auditors for the period commencing January 1, 2006 and ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

21


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

716933106

 

PCYC

 

Pharmacyclics, Inc.

 

 

 

 

 

 

Meeting Date:

 

12/15/2005

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

10/20/2005

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Miles R. Gilburne

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Loretta M. Itri, M.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Richard M. Levy, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Richard A. Miller, M.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director William R. Rohn

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Craig C. Taylor

 

For

 

Yes

 

For

 

Management

2

 

To amend the company’s 2004 equity incentive award plan (“the 2004 Plan”) in order to increase the total number of shares of common stock authorized for issuance over the term of the 2004 Plan by an additional 1,000,000 shares.

 

For

 

Yes

 

Against

 

Management

3

 

To ratify the appointment of Pricewaterhousecoopers LLP as the company’s independent registered public accounting firm for the fiscal year ending June 30, 2006.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

PHT Corporation

 

 

 

 

 

 

 

Action by Written Consent:

 

12/27/2005

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Authorize to enter into, execute and deliver, and perform its obligations under a loan agreement

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

Raven biotechnologies, Inc.

 

 

 

 

 

 

 

Action by Written Consent:

 

7/7/2005

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approve amendment to restated certificate

 

For

 

Yes

 

For

 

Management

2

 

Approve subsequent closing investors per agreement

 

For

 

Yes

 

For

 

Management

 

22


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

 

 

 

Raven biotechnologies, Inc.

 

 

 

 

 

 

 

Action by Written Consent:

 

7/28/2005

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approve amendment to restated certifcate

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

Raven biotechnologies, Inc.

 

 

 

 

 

 

 

Action by Written Consent:

 

9/23/2005

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approve amendment to restated certificate

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

Raven biotechnologies, Inc.

 

 

 

 

 

 

 

Action by Written Consent:

 

9/30/2005

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approve financing

 

For

 

Yes

 

For

 

Management

2

 

Approve restated certificate

 

For

 

Yes

 

For

 

Management

3

 

Approve plan amendment

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

Raven biotechnologies, Inc.

 

 

 

 

 

 

 

Action by Written Consent:

 

3/10/2006

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approve restated certificate

 

For

 

Yes

 

For

 

Management

2

 

Approve waiver of any default

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

Raven biotechnologies, Inc.

 

 

 

 

 

 

 

Action by Written Consent:

 

4/20/2006

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approve amendment to restated certificate

 

For

 

Yes

 

For

 

Management

2

 

Elect Director William R. Rohn, Ph.D.

 

For

 

Yes

 

For

 

Management

3

 

Elect Director George F. Schreiner, M.D., Ph.D.

 

For

 

Yes

 

For

 

Management

 

766559603

 

RIGL

 

Rigel Pharmaceuticals, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/30/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/6/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director James M. Gower

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Gary A. Lyons

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Donald G. Payan

 

For

 

Yes

 

For

 

Management

2

 

To approve the company’s 2000 equity incentive plan, as amended, as more fully described in the accompanying proxy statement

 

For

 

Yes

 

Against

 

Management

3

 

To ratify the selection by the audit committee of the board of directors of Ernst & Young LLP as independent registered public accounting firm of company for its fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

23


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

800677106

 

SGMO

 

Sangamo Biosciences, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/7/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/27/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Edward O. Lanphier, II

 

For

 

Yes

 

For

 

Management

1

 

Elect Director William G. Gerber, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect Director John W. Larson

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Margaret A. Liu, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Steven J. Mento, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director H. Ward Wolff

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Michael C. Wood

 

For

 

Yes

 

For

 

Management

2

 

To ratify the appointment of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

812578102

 

SGEN

 

Seattle Genetics, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/19/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/21/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Clay B. Siegall

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Daniel F. Hoth

 

For

 

Yes

 

For

 

Management

2

 

Proposal to ratify the appointment of Pricewaterhousecoopers LLP as the independent registered public accounting frim of the company for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

3

 

Proposal to approve the issuance and sale of 1,129,015 of common stock to entities affiliated with Baker Brothers Investments for $5.25 per share pursuant to the stock purchase agreement dated March 28, 2006

 

For

 

Yes

 

For

 

Management

 

24


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

81724Q107

 

SNMX

 

Senomyx, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/24/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/3/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Stephen A. Block, Esq.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Michael E. Herman

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Mark Leschly

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Dennis F. O’Brien

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Jay M. Short, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Kent Snyder

 

For

 

Yes

 

For

 

Management

1

 

Elect Christopher J. Twomey

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection by the audit committee of our board of directors of Ernst & Young LLP as our independent auditors for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

829669100

 

RNAI

 

Sirna Therapeutics, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/14/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

5/1/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Jeremy L. Curnock Cook

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Dennis H. Langer

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Lutz Lingnau

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Howard W. Robin

 

For

 

Yes

 

For

 

Management

2

 

Proposal to approve the amendments to the company’s 2005 performance incentive plan

 

For

 

Yes

 

For

 

Management

3

 

Proposal for ratification of appointment of Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

87959M109

 

TELK

 

Telik, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

5/25/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/28/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Dr. Stefan Ryser, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Robert W. Frick

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Mary Ann Gray, Ph.D.

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of Ernst & Young LLP as independent registered public accounting firm of the company for its fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

3

 

To approve an amendment to the company’s 2000 non-employee directors’ stock option plan to increase the number of shares of common stock reserved for future issuance by 300,000 shares.

 

For

 

Yes

 

For

 

Management

 

25


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

88078L105

 

TRCA

 

Tercica, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/6/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/17/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Alexander Barkas, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Dennis Henner, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Mark Leschly

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of Ernst & Young LLP as Tercica’s independent registered public accounting firm for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

881624209

 

TEVA

 

Teva Pharmaceutical Industries Ltd. ADR

 

 

 

 

 

 

Meeting Date:

 

7/19/2005

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

6/20/2005

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To receive and discuss the company’s consolidated balance sheet and the consolidated statements of income.

 

For

 

Yes

 

For

 

Management

2

 

To approve the Board of Director’s recommendation that the cash dividend for the year ended December 31, 2004.

 

For

 

Yes

 

For

 

Management

3

 

To appoint Dr. Leora (Rubin) Meridor as a statutory independent director for an additional term of three years

 

For

 

Yes

 

For

 

Management

4

 

To elect Eli Hurvitz to serve for an additional three-year term

 

For

 

Yes

 

For

 

Management

4

 

To elect Ruth Cheshin to serve for an additional three-year term

 

For

 

Yes

 

For

 

Management

4

 

To elect Prof. Michael Sela to serve for an additional three-year term

 

For

 

Yes

 

For

 

Management

4

 

To elect Harold Snyder to serve for an additional three-year term

 

For

 

Yes

 

For

 

Management

5

 

To approve the purchase of director’s and officer’s liability insurance for the the directors and officers of the company.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

 

 

 

 

 

 

6

 

To approve the company’s 2005 omnibus long-term share incentive plan.

 

For

 

Yes

 

For

 

Management

7

 

To approve an amendment to provisions of the company’s articles relating to the idemnifation of directors and officers

 

For

 

Yes

 

For

 

Management

8

 

To approve an amendment to the company’s articles that would increase the registered share capital of the company

 

For

 

Yes

 

For

 

Management

9

 

To appoint Kesselman & Kesselman, a member of Pricewaterhousecoopers International Ltd., as the company’s independent registered public accounting firm and to determine their compensation

 

For

 

Yes

 

For

 

Management

 

26


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

881624209

 

TEVA

 

Teva Pharmaceutical Industries Ltd. ADR

 

 

 

 

 

 

Meeting Date:

 

10/27/2005

 

 

 

Meeting Type:

 

Special

 

 

 

 

Record Date:

 

9/30/2005

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To approve the issuance of ordinary shares of Teva, pursuant to the agreement and plan of merger, dated July 25, 2005, by and among Ivax Corporation, Teva and two wholly owned subsidiaries of Teva, Ivory Acquisition Sub, Inc. and Ivory Acquisition Sub II, Inc.

 

For

 

Yes

 

For

 

Management

 

881624209

 

TEVA

 

Teva Pharmaceutical Industries Ltd. ADR

 

 

 

 

 

 

Meeting Date:

 

5/4/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/27/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To receive and discuss the company’s consolidated blance sheet as of December 31, 2005 and the consolidated statements of income for the year then ended.

 

For

 

Yes

 

For

 

Management

2

 

To approve the board of directors’ recommendation that the cash dividend for the year ended December 31, 2005 be declared final.

 

For

 

Yes

 

For

 

Management

3

 

To appoint Prof. Gabriela Shalev as a statutory independent director for an additional term of three years.

 

For

 

Yes

 

For

 

Management

4

 

To elect the following director to serve for a three-year term: Dr. Phillip Frost

 

For

 

Yes

 

For

 

Management

4

 

To elect the following director to serve for a three-year term: Carlo Salvi

 

For

 

Yes

 

For

 

Management

4

 

To elect the following director to serve for a three-year term: David Shamir

 

For

 

Yes

 

For

 

Management

5

 

To approve the purchase of director’s and officer’s liability insurance for the directors and officers of the company

 

For

 

Yes

 

For

 

Management

6

 

To approve an amendment to section 60(E) of the company’s articles of association.

 

For

 

Yes

 

For

 

Management

7

 

To approve an increase in the renumeration paid to directors of the company (other than the chairman of the board)

 

For

 

Yes

 

For

 

Management

8

 

To appoint Kesselman & Kesselman, as the independent registered public accounting firm and to determine their compensation

 

For

 

Yes

 

For

 

Management

 

27


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

88338T104

 

THRX

 

Theravance, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

4/26/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

3/1/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director P. Roy Vagelos, M.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Rick E. Winningham

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Julian C. Baker

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Jeffrey M. Drazan

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Robert V. Gunderson, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Arnold J. Levine, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Ronn C. Loewenthal

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Eve E. Slater, M.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director William H. Waltrip

 

For

 

Yes

 

For

 

Management

1

 

Elect Director G.M. Whitesides, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director William D. Young

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection by the audit committee of the board of directors of Ernst & Young LLP as the independent registered public accounting firm of Theravance, Inc. for its fiscal year ending December 31, 2006.

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

Therion Biologics Corporation

 

 

 

 

 

 

 

Action by Written Consent:

 

1/4/2006

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To approve the certificate of amendment to certificate of incorporation

 

For

 

No

 

None

 

Management

2

 

Increase in shares reserved under 1998 stock plan

 

For

 

No

 

None

 

Management

 

 

 

 

 

Therox, Inc.

 

 

 

 

 

 

 

Action by Written Consent:

 

9/15/2005

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Ray Larkin

 

For

 

No

 

None

 

Management

 

88428W108

 

TWTI

 

Third Wave Technologies, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/13/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/14/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Gordon Brunner

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Lawrence Murphy

 

For

 

Yes

 

For

 

Management

2

 

To ratify the appointment of Grant Thornton LLP as independent registered public accounting firm of the company for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

28


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

928551100

 

VVUS

 

Vivus, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/14/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/24/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Virgil A. Place, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Leland F. Wilson

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Mark B. Logan

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Mario M. Rosati

 

For

 

Yes

 

For

 

Management

1

 

Elect Director L.M.D. Shortliffe, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Graham Strachan

 

For

 

Yes

 

For

 

Management

2

 

Ratification of the appointment of Ondenberg, Ullakko, Muranishi & Co. LLP as the independent public auditors of the company for the fiscal year ending December 31, 2006

 

For

 

Yes

 

For

 

Management

 

928566108

 

VNUS

 

VNUS Medical Technologies, Inc.

 

 

 

 

 

 

Meeting Date:

 

5/25/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/3/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Kathleen D. Laporte

 

For

 

Yes

 

For

 

Management

1

 

Elect Lori M. Robson, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Gregory T. Schiffman

 

For

 

Yes

 

For

 

Management

2

 

Ratification of appointment of independent registered public accounting firm to be Pricewaterhousecoopers LLP

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

Xanthus Pharmaceuticals, Inc.

 

 

 

 

 

 

 

Action by Written Consent:

 

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approve an amendment of the certificate of incorporation

 

For

 

Yes

 

For

 

Management

2

 

Approve the issuance of securities

 

For

 

Yes

 

For

 

Management

3

 

Approve waiver of rights of first refusal

 

For

 

Yes

 

For

 

Management

 

29


 

CUSIP

 

Symbol

 

Company Name

 

 

 

 

 

 

 

 

 

 

 

Xanthus Pharmaceuticals, Inc.

 

 

 

 

 

 

 

Action by Written Consent:

 

1/27/2006

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approve an amendment to the certificate of incorporation

 

For

 

Yes

 

For

 

Management

2

 

Approve an amendment to the stockholder’s agreement

 

For

 

Yes

 

For

 

Management

3

 

Approve office of the Company his or her true lawful agent with power of attorney

 

For

 

Yes

 

For

 

Management

 

 

 

 

 

Xanthus Pharmaceuticals, Inc.

 

 

 

 

 

 

 

Action by Written Consent:

 

2/3/2006

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approve an amendment to the certificate of incorporation

 

For

 

Yes

 

For

 

Management

 

98985T109

 

ZGEN

 

Zymogenetics, Inc.

 

 

 

 

 

 

 

 

Meeting Date:

 

6/15/2006

 

 

 

Meeting Type:

 

Annual

 

 

 

 

Record Date:

 

4/10/2006

 

 

 

 

 

 

 

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Judith A. Hemberger, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director David I. Hirsh, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Director David H. Maccallum,

 

For

 

Yes

 

For

 

Management

1

 

Elect Director Kurt Anker Nielsen

 

For

 

Yes

 

For

 

Management

2

 

Approval of 2001 stock incentive plan

 

For

 

Yes

 

For

 

Management

3

 

Appointment of Pricewaterhousecoopers LLP

 

For

 

Yes

 

For

 

Management

 

30


 

SIGNATURES

 

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

(Registrant)

  H&Q Life Sciences Investors

 

By (Signature and Title)*

 

 

(Daniel Omstead, President)

 

 /s/ Daniel Omstead

 

 

Date

 8/31/06

 

*Print the name and title of each signing officer under his or her signature.